WHO ICTRP trial
Evaluation of most adequate pain medication in uterine artery embolisation for…
NL-OMON29678 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON29678 |
|---|---|
| Public title | Evaluation of most adequate pain medication in uterine artery embolisation for fibroma: PCA versus Epidural Analgesia. |
| Scientific title | PCA and ketamin versus Epidural Analgesia in pain management of uterine artery embolization in symptomatic uterine leiomyomata. |
| Primary sponsor | Onze Lieve Vrouwe Gasthuis, Amsterdam (OLVG) |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | symptomatic uterine leiomyomata embolization post procedural pain epidural analgesia patient controlled analgesia |
| Interventions | Uterine artery embolization group 1: PCA (morphin + ketamin) group 2: epidural analgesia (bupivacain/naropin) both groups: PCM, diclofenac, tramadol |
| Registration date | Nov 18, 2008 |
| Target size | 100 |
| Secondary IDs | NL1474;NTR1543; : ;ISRCTN wordt niet meer aangevraagd |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: